Literature DB >> 10626824

Peritoneal sclerosis.

N Di Paolo1, G Garosi.   

Abstract

The term "peritoneal sclerosis" encompasses a vast range of peritoneal alterations, from the manifestations of low clinical impact constantly associated with peritoneal dialysis, to dramatic thickening of the peritoneal membrane, which is rare, but often life-threatening. The epidemiology, pathology, etiopathogenesis, clinical manifestations, diagnostic criteria, therapy and prevention of peritoneal sclerosis are reviewed.

Entities:  

Mesh:

Year:  1999        PMID: 10626824

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  5 in total

1.  Effect of bevacizumab, a vascular endothelial growth factor inhibitor, on a rat model of peritoneal sclerosis.

Authors:  Sibel Ada; Sibel Ersan; Aykut Sifil; Mehtat Unlu; Efsun Kolatan; Mehmet Sert; Sulen Sarioglu; Osman Yilmaz; Taner Camsari
Journal:  Int Urol Nephrol       Date:  2015-10-03       Impact factor: 2.370

2.  Network-based integrated analysis of omics data reveal novel players of TGF-β1-induced EMT in human peritoneal mesothelial cells.

Authors:  Soo Min Han; Hye-Myung Ryu; Jinjoo Suh; Kong-Joo Lee; Soon-Youn Choi; Sangdun Choi; Yong-Lim Kim; Joo Young Huh; Hunjoo Ha
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

3.  Clinical characteristics of dialysis related sclerosing encapsulating peritonitis: multi-center experience in Korea.

Authors:  Beom Seok Kim; Hoon Young Choi; Dong-Ryeol Ryu; Tae Hyun Yoo; Hyeong Cheon Park; Shin Wook Kang; Kyu Hun Choi; Sung Kyu Ha; Dae Suk Han; Ho Yung Lee
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

4.  Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?

Authors:  Jesús Loureiro; Guadalupe Gónzalez-Mateo; José Jimenez-Heffernan; Rafael Selgas; Manuel López-Cabrera; Abelardo Aguilera Peralta
Journal:  Int J Nephrol       Date:  2013-02-10

Review 5.  Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis.

Authors:  Manuel López-Cabrera
Journal:  Adv Med       Date:  2014-01-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.